Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 23(3)2022 Jan 18.
Article in English | MEDLINE | ID: mdl-35162938

ABSTRACT

Extracellular vesicles (EVs) released by bone marrow stromal cells (BMSCs) have been shown to act as a transporter of bioactive molecules such as RNAs and proteins in the therapeutic actions of BMSCs in various diseases. Although EV therapy holds great promise to be a safer cell-free therapy overcoming issues related to cell therapy, manufacturing processes that offer scalable and reproducible EV production have not been established. Robust and scalable BMSC manufacturing methods have been shown to enhance EV production; however, the effects on EV quality remain less studied. Here, using human BMSCs isolated from nine healthy donors, we examined the effects of high-performance culture media that can rapidly expand BMSCs on EV production and quality in comparison with the conventional culture medium. We found significantly increased EV production from BMSCs cultured in the high-performance media without altering their multipotency and immunophenotypes. RNA sequencing revealed that RNA contents in EVs from high-performance media were significantly reduced with altered profiles of microRNA enriched in those related to cellular growth and proliferation in the pathway analysis. Given that pre-clinical studies at the laboratory scale often use the conventional medium, these findings could account for the discrepancy in outcomes between pre-clinical and clinical studies. Therefore, this study highlights the importance of selecting proper culture conditions for scalable and reproducible EV manufacturing.


Subject(s)
Culture Media/chemistry , Extracellular Vesicles/genetics , Mesenchymal Stem Cells/cytology , MicroRNAs/analysis , Cell Culture Techniques , Cell Proliferation , Cells, Cultured , Healthy Volunteers , Humans , Mesenchymal Stem Cells/metabolism , Sequence Analysis, RNA , Signal Transduction
2.
Plant Physiol ; 183(3): 1110-1125, 2020 07.
Article in English | MEDLINE | ID: mdl-32350121

ABSTRACT

Auxin is a crucial plant growth regulator. Forward genetic screens for auxin-related mutants have led to the identification of key genes involved in auxin biosynthesis, transport, and signaling. Loss-of-function mutations in genes involved in glucosinolate biosynthesis, a metabolically related route that produces defense compounds, result in auxin overproduction. We identified an allelic series of fertile, hypomorphic Arabidopsis (Arabidopsis thaliana) mutants for the essential glucosinolate biosynthetic gene ROOTY (RTY) that exhibit a range of phenotypic defects characteristic of enhanced auxin production. Genetic characterization of these lines uncovered phenotypic suppression by cyp79b2 cyp79b3, wei2, and wei7 mutations and revealed the phenomenon of interallelic complementation in several RTY transheterozygotes. Structural modeling of RTY elucidated the relationships between structure and function in the RTY homo- and heterodimers, and unveiled the likely structural basis of interallelic complementation. This work underscores the importance of employing true null mutants in genetic complementation studies.


Subject(s)
Alleles , Arabidopsis Proteins/genetics , Arabidopsis/genetics , Carbon-Sulfur Lyases/genetics , Genetic Complementation Test , Arabidopsis Proteins/chemistry , Arabidopsis Proteins/metabolism , Binding Sites , Carbon-Sulfur Lyases/chemistry , Carbon-Sulfur Lyases/metabolism , Cotyledon/genetics , Genetic Loci , Heterozygote , Models, Molecular , Mutation/genetics , Phenotype , Plants, Genetically Modified , Protein Multimerization , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...